CytomX Therapeutics (CTMX)
(Delayed Data from NSDQ)
$4.19 USD
+0.12 (2.95%)
Updated May 8, 2024 04:00 PM ET
After-Market: $2.78 -1.41 (-33.65%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | *AMC5/8/24 |
---|---|
Current Quarter | -0.06 |
EPS Last Quarter | 0.01 |
Last EPS Surprise | -50.00% |
ABR | 2.43 |
Earnings ESP
|
-126.09% |
---|---|
Current Year | -0.36 |
Next Year | -0.42 |
EPS (TTM) | -0.02 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 23.40M | 23.65M | 95.15M | 89.23M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 27.00M | 27.00M | 108.00M | 108.00M |
Low Estimate | 20.00M | 20.00M | 80.00M | 80.00M |
Year ago Sales | 23.50M | 24.72M | 101.21M | 95.15M |
Year over Year Growth Est. | -0.42% | -4.32% | -6.00% | -6.22% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.06 | -0.07 | -0.36 | -0.42 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | 0.02 | 0.01 | 0.04 | -0.17 |
High Estimate | 0.02 | 0.01 | 0.04 | -0.17 |
Low Estimate | -0.15 | -0.15 | -0.75 | -0.70 |
Year ago EPS | -0.05 | -0.02 | -0.01 | -0.36 |
Year over Year Growth Est. | -20.00% | -250.00% | -3,500.00% | -16.67% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 1 | 1 | 1 | 1 |
Down Last 30 Days | 1 | 1 | 2 | 2 |
Down Last 60 Days | 2 | 2 | 4 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.06 | -0.07 | -0.36 | -0.42 |
7 Days Ago | -0.03 | -0.04 | -0.25 | -0.32 |
30 Days Ago | 0.00 | 0.00 | -0.15 | -0.21 |
60 Days Ago | -0.01 | -0.01 | -0.03 | -0.19 |
90 Days Ago | -0.07 | -0.07 | -0.03 | -0.19 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.13 | -0.15 | -0.66 | -0.60 |
Zacks Consensus Estimate | -0.06 | -0.07 | -0.36 | -0.42 |
Earnings ESP | -126.09% | -107.14% | -85.92% | -44.58% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.01 | 0.04 | -0.02 | -0.05 | NA |
Estimate | 0.02 | -0.17 | -0.19 | -0.16 | NA |
Difference | -0.01 | 0.21 | 0.17 | 0.11 | 0.12 |
Surprise | -50.00% | 123.53% | 89.47% | 68.75% | 57.94% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more